Lallemand Health Solutions is excited to announce the launch of Innov’Biome, an open innovation challenge inviting start-ups, companies, universities, and research laboratories to participate throughout April and May 2025.
Morgane Maillard, Marketing Innovation Manager at Lallemand Health Solutions, explains, “As we continue to explore the vast potential of microbiome-based solutions, we are seeking new probiotic strains, postbiotics, next-generation strains, and groundbreaking applications that can make a real impact on human health and nutrition. Collaboration has always been part of our DNA, and now we want to take it to the next level!”
Targeted health areas
Lallemand Health Solutions welcomes applications from entities with scientifically documented strains for both traditional and innovative health applications, for human health. The company is particularly interested in solutions for healthy aging, women’s health, and gut health and remains open to receiving and analyzing innovative biotic solutions in other health segments.
Mélanie Le Barz, Scientific Innovation Manager, adds “While gastrointestinal health is still the main reason for probiotic use, new areas require high-quality research with trials tailored to specific populations, such as women and aging individuals. Both market needs and science are evolving quickly, and we believe that biotic approaches are relevant to support health and quality of life.”
Why partner with Lallemand Health Solutions?
Participants can leverage Lallemand Health Solutions' global expertise to increase their presence on the food and dietary supplement markets with their biotic solutions. From production to promotion at the BtoB level, entities can capitalise on Lallemand’s extensive knowledge in research, processes, formulation, regulatory and marketing support. The company provides comprehensive, end-to-end solutions, ensuring products reach customers worldwide, thanks to its dedicated sales team.
